SCHEMBL5720125

SCHEMBL5720125

CCc1ccccc1CN1CCC(N2CCC(c3ccc4c(c3)[N]C(=O)N4)CC2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 9/20 0.41
DRD2 P14416 3/20 0.41
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
CHRM5 P08912 1/20 0.41
CHRM3 P20309 1/20 0.41
ADRA1D P25100 1/20 0.41
HTR2C P28335 1/20 0.41
ADRA1A P35348 1/20 0.41
ADRA1B P35368 1/20 0.41
TRPV6 Q9H1D0 2/20 0.39
TLR9 Q9NR96 5/20 0.39
TLR7 Q9NYK1 5/20 0.39
PARP1 P09874 1/20 0.38
ALDH1A1 P00352 2/20 0.38
TSHR P16473 1/20 0.38
RECQL P46063 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KDM4E B2RXH2 1/20 0.37
TLR8 Q9NR97 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5720092 0.91 CHRM1 (0.51) CHRM1DRD2CHRM2CHRM4CHRM5
SCHEMBL5720263 0.89 CHRM1 (0.38) CHRM1DRD2CHRM2CHRM4CHRM5
SCHEMBL5720312 0.89 DRD2 (0.40) CHRM1DRD2CHRM2CHRM4CHRM5
SCHEMBL5720385 0.87 CHRM1 (0.53) CHRM1DRD2TRPV6PARP1ALDH1A1
SCHEMBL5720132 0.84 TRPV6 (0.41) CHRM1DRD2CHRM2CHRM4CHRM5
SCHEMBL5719999 0.82 CHRM2 (0.45) DRD2CHRM2CHRM3TLR9TLR7
SCHEMBL5720388 0.81 DRD2 (0.40) DRD2TRPV6TLR9TLR7PARP1
SCHEMBL5720269 0.80 DRD2 (0.39) DRD2TRPV6TLR9TLR7ALDH1A1
SCHEMBL5720279 0.80 DRD2 (0.41) CHRM1DRD2CHRM2CHRM4CHRM5
SCHEMBL5720128 0.79 TLR7 (0.44) DRD2TRPV6TLR9TLR7PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1515722-A4 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO INC (US) 2006-06-21 EP disclosed
EP-1515722-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION Merck & Co., Inc. (US) 2005-03-23 EP disclosed
WO-2003105781-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO., INC. (US) 2003-12-24 WO disclosed